Filing Details
- Accession Number:
- 0000899243-21-022208
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-07 06:03:14
- Reporting Period:
- 2021-06-02
- Accepted Time:
- 2021-06-07 06:03:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1809519 | Goodrx Holdings Inc. | GDRX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1632311 | Bansi Nagji | C/O Goodrx Holdings, Inc. 2701 Olympic Boulevard Santa Monica CA 90404 | President, Healthcare | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2021-06-02 | 45,998 | $6.84 | 75,164 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2021-06-02 | 45,998 | $40.07 | 29,166 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Stock Option (Right to Buy) | Disposition | 2021-06-02 | 45,998 | $0.00 | 45,998 | $6.84 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
624,836 | 2030-06-15 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.29. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The option has vested and became exercisable or will vest and become exercisable with respect to the original 670,834 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on June 10, 2020.